Belite Bio (BLTE) Shares Issued (2023 - 2025)
Belite Bio's quarterly Shares Issued came in at $49.3 million in Q4 2025, up 127.92% quarter-over-quarter from $21.7 million in Q4 2023.
Belite Bio has reported Shares Issued for 2 years, with the latest figure at $49.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - | 49.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.35 Mn |
| Dec 31, 2025 | 49.35 Mn |
| Dec 31, 2024 | 688,000.00 |
| Dec 31, 2024 | 688,000.00 |
| Dec 31, 2023 | 21.65 Mn |
| Dec 31, 2023 | 21.65 Mn |